-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Oncotelic Therapeutics, Inc. quarterly and annual Revenues history and change rate from 2020 to 2023.
- Oncotelic Therapeutics, Inc. Revenues for the quarter ending 30 Sep 2023 was $70,000.
- Oncotelic Therapeutics, Inc. annual Revenues for 2023 was $70,000.